After earning his doctorate in biochemistry in 1979, Horst Domdey worked as a scientist at various German, Swiss and US institutes such as the Max Planck Institute of Biochemistry, the ISREC, the UCSD and the California Institute of Technology. From 1984 to 1994 he headed an independent research group at the Gene Center of the LMU Munich where he was appointed Professor of Biochemistry in 1994. In the same year he co-founded MediGene, one of the first German biotech companies. In 1996 he successfully led the Munich Biotech Initiative into the German BioRegio Competition. Since 1997 he has been the Managing Director of BioM, the cluster development and management organization of the Munich Biotech Cluster. Since 2006 he also oversees the Bavarian Biotechnology Network. From 2010 to 2015, he was the spokesman of the Munich leading edge cluster program m4 – Personalized Medicine m4. Among others he is member of the Supervisory Board of Medigene AG, of the Advisory Board of GNA Biosolutions, of the boards of the Peter and Traudl Engelhorn Foundation and the Foundation for Stem Cell Research and Applied Regenerative Medicine, of the Advisory Board of FCF Fox Corporate Finance, and of the Translational Research Group of the German Centre for Cardiovascular Research.
Managed by BioM Biotech Cluster Development GmbH
Copyright © 2023 BioM Biotech Cluster Development GmbH
Alle Rechte vorbehalten